A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.
Stryjewski, Martin E
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study. [electronic resource] - BMC infectious diseases May 2014 - 289 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1471-2334
10.1186/1471-2334-14-289 doi
Adult
Aged
Aged, 80 and over
Aminoglycosides--adverse effects
Anti-Bacterial Agents--therapeutic use
Bacteremia--drug therapy
Catheter-Related Infections--complications
Double-Blind Method
Female
Humans
Lipoglycopeptides
Male
Methicillin-Resistant Staphylococcus aureus--drug effects
Middle Aged
Penicillins--therapeutic use
Staphylococcal Infections--drug therapy
Staphylococcus aureus--drug effects
Treatment Outcome
Vancomycin--therapeutic use
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study. [electronic resource] - BMC infectious diseases May 2014 - 289 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1471-2334
10.1186/1471-2334-14-289 doi
Adult
Aged
Aged, 80 and over
Aminoglycosides--adverse effects
Anti-Bacterial Agents--therapeutic use
Bacteremia--drug therapy
Catheter-Related Infections--complications
Double-Blind Method
Female
Humans
Lipoglycopeptides
Male
Methicillin-Resistant Staphylococcus aureus--drug effects
Middle Aged
Penicillins--therapeutic use
Staphylococcal Infections--drug therapy
Staphylococcus aureus--drug effects
Treatment Outcome
Vancomycin--therapeutic use